Omission of Surgical Axillary Staging Noninferior To Sentinel Lymph Node Biopsy in Patients with cN0, T1 or T2 Invasive Breast Cancer By Ogkologos - January 14, 2025 864 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the INSEMA study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR PDX Mouse Models Are Reliable Stand-Ins for Human Tumors, Study Finds February 2, 2021 Second- or Third-Line Treatment with Tisotumab Vedotin Results in Greater Efficacy... July 12, 2024 Talazoparib Plus Enzalutamide Improves rPFS Over Placebo Plus Enzalutamide in First-Line... June 7, 2023 Woman Dances Through Chemo Sessions, Emphasizes Importances of Being ‘Joyful’ March 4, 2021 Load more HOT NEWS EMA’s Safety Committee Has Concluded That the Benefits of Ifosfamide Solutions... Cómo mantenerse seguro e independiente durante el tratamiento contra el cáncer A winding journey into the world of children’s and young people’s... Apalutamide Plus ADT Demonstrates a Rapid, Deep, and Durable PSA Decline...
